News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 73–108
- Matches
- 303
- Sources here
- 15
- Companies here
- 10
Active search
303 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
All eyes on National Health Investors earnings as revenue declines By Investing.com
National Health Investors Inc. is set to report its second-quarter earnings, with analysts anticipating a 10% EPS increase year-over-year but a 22% decline in revenue. Investors will be closely watching whether the revenue contraction is due to strategic portfolio repositioning or operational challenges, especially …
Is National Health Investors (NHI) Undervalued After Its New COO Appointment?
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. National Health Investors (NHI) stock is drawing fresh attention after the company named senior housing veteran Chris Maingot as Chief Operating Officer, effective July …
Inhibikase Therapeutics, Inc. expected to post a loss of 11 cents a share - Earnings Preview
Inhibikase Therapeutics, Inc. is projected to report a loss of 11 cents per share in its upcoming earnings. This article serves as an earnings preview, indicating the anticipated financial performance for the company.
National Health Investors Q2 2026 Earnings Preview
* National Health Investors (NHI [https://seekingalpha.com/symbol/NHI]) is scheduled to announce Q2 earnings results on Monday, August 10th, after market close. * The consensus FFO estimate is $1.25, [https://seekingalpha.com/symbol/NHI/earnings/estimates] and the consensus revenue estimate is $112.51M * Over the last year, NHI has beaten EPS …
Wall Street Zen Upgrades Inhibrx Biosciences (NASDAQ:INBX) to "Hold"
Wall Street Zen has upgraded Inhibrx Biosciences (NASDAQ:INBX) from a "Sell" to a "Hold" rating, bringing the consensus rating for the stock to "Hold" with an average price target of $150. This upgrade comes despite the company reporting a quarterly loss of $2.15 per …
Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Given Consensus Recommendation of "Buy" by Brokerages
Inhibikase Therapeutics, Inc. (NASDAQ:IKT) has received a consensus "Buy" recommendation from nine brokerages, with an average 12-month price target of $5.40. The company's shares recently opened at $2.47, up 2.5%, with a market capitalization of $326.11 million. Several institutional investors, including Goldman Sachs Group …
Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp (NYSE:SBS) Upgraded to "Buy" at Wall Street Zen
Wall Street Zen has upgraded Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp (NYSE:SBS) from "Hold" to "Buy," though the broader analyst consensus remains a "Moderate Buy" with a $183.00 target price. The company recently reported quarterly results that missed expectations, …
NATIONAL HEALTH INVESTORS Q2 2026 Earnings Preview: Recent $NHI Insider Trading, Hedge Fund Activity, and More
NATIONAL HEALTH INVESTORS (NHI) is set to release its Q2 2026 earnings on August 10th, with analysts projecting $112.8 million in revenue and $0.86 EPS. Recent insider activity shows two purchases in the last six months, totaling over $160,000, while institutional investors have shown …
Companhia de Saneamento Basico do Estado de Sao Paulo - SABESP (SBS) Stock News Today
This article provides current stock information for Companhia de Saneamento Basico do Estado de
Sharemaestro market context Trend signal ended 52 weeks +27.9% · Next-week setup positive 59.5%Notícias das Ações da Companhia de Saneamento Basico do Estado de Sao Paulo - SABESP (SBS)
This article provides an overview of the Companhia de Saneamento Basico do Estado de Sao Paulo - SABESP (SBS) stock, including its current trading price, market capitalization, and P/E ratio. It directs readers to follow the platform for the latest news, financial results, and …
The Bull Case For National Health Investors (NHI) Could Change Following Appointment Of Veteran COO Chris Maingot
National Health Investors (NHI) recently appointed Chris Maingot, a veteran in senior housing leadership, as its Chief Operating Officer. This strategic hire is expected to influence NHI's management of senior housing assets and growth initiatives, particularly as the company focuses on operational performance and …
CSNA3: Higher Future P/E Will Support Upside Despite Margin Pressure
Analysts have reduced their price target for Companhia Siderúrgica Nacional (CSNA3) from R$8.30 to R$7.45, a 10% decrease, primarily due to a lower projected net profit margin and a slightly higher discount rate. Despite these adjustments, a higher future P/E multiple is expected to …
State Street (NHI holder) discloses 2.74M National Health Investors shares in 13G
State Street Corporation has filed a Schedule 13G, disclosing a beneficial ownership of 2,735,937 shares of National Health Investors, Inc. (NHI) common stock, which represents a 5.6% stake in the company as of June 30, 2026. The filing indicates that State Street exercises shared …
Copel Finalizes R$150 Million Sale of Dona Francisca Hydroelectric Stake to Gerdau
Copel has completed the sale of its 23.03% stake in Dona Francisca Energética S.A. to Gerdau S.A. for R$150.7 million. This divestment aligns with Copel’s strategy to optimize its asset portfolio and simplify its corporate structure, aiming to enhance shareholder value and improve service …
Copel Q2 2026 slides: EBITDA surges 21% on operational gains
Brazilian utility Copel (CPLE3) reported strong Q2 2026 results with recurring EBITDA up 20.8% to R$1,612.6 million and recurring net income soaring 42.6% to R$645.1 million, driven by operational gains in its distribution and generation segments. The company is executing a significant capital investment …
Companhia Paranaense de Energia Files August 2026 Form 6-K as Foreign Issuer
Companhia Paranaense de Energia (Copel) has filed its August 2026 Form 6-K with the U.S. SEC, confirming its status as a foreign private issuer. This filing, signed by CEO Daniel Slaviero, primarily fulfills regulatory requirements and reiterates standard forward-looking risks without signaling new operational …
Copel Posts Strong 2Q26 Earnings, Boosts Investments and Shareholder Payouts
Copel (ELPC) reported strong operational and financial results for Q2 2026, with recurring EBITDA rising 20.8% and net income increasing 42.6%. The company maintained its leverage, invested significantly in capital expenditures, and returned substantial funds to shareholders through dividends and interest on equity. An …
Copel Achieves 20.8% Increase in Recurring EBITDA in 2Q26 Recurring
Net Income Jumps 42.6%, Driven by Operational Efficiency, Strong Expansion in the Distribution Market, and a Highly Effective Commercial Strategy Curitiba, Brazil--(Newsfile Corp. - August 5, 2026) - Copel (NYSE American: ELPC) (BVMF: CPLE3) closed the second quarter of 2026 with strong financial and …
Companhia de Saneamento Basico do Estado de Sao Paulo - SABESP (SBS) Earnings Forecast: Future EPS & Revenue Growth Estimates
Companhia de Saneamento Basico do Estado de Sao Paulo - SABESP (SBS) has an earnings forecast score of 9.00, ranking 1st in its industry. Analysts have set an average price target of $29.90 for SBS, with a strong buy consensus based on 4 analysts. …
CSN seeking $2.9B for sale of cement unit - Bloomberg (SID:NYSE)
Companhia Siderúrgica Nacional (CSN) is reportedly seeking at least $2.9 billion for the sale of its cement business. The Brazilian steelmaker expects to receive four bids as it moves to sell the entire unit, abandoning an earlier plan.
Lazard Asset Management LLC Makes New Investment in National Health Investors, Inc. $NHI
Lazard Asset Management LLC has made a new investment in National Health Investors, Inc. (NYSE:NHI), purchasing 18,012 shares valued at approximately $1.46 million. This investment comes as institutional investors collectively own 62.51% of the REIT, and company insiders have also increased their holdings. Despite …
Inhibrx Biosciences (INBX) to Announce Quarterly Earnings on Wednesday
Inhibrx Biosciences (INBX) is scheduled to announce its Q2 2026 earnings before market open on Wednesday, August 12th. Analysts predict a loss of $2.28 per share, following a previous quarter where the company missed expectations with a $2.15 per share loss. The stock, which …
Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp (SBS) Expected to Post Quarterly Earnings on Wednesday
Companhia de Saneamento Básico do Estado de São Paulo (SABESP) is expected to report its Q2 2026 earnings before market open on Wednesday, August 12th, with analysts forecasting earnings of $0.0899 per share and revenue of $1.2421 billion. This follows a previous quarter where …
Sharemaestro market context Trend signal ended 52 weeks +27.9% · Next-week setup positive 59.5%ETFs Investing in National Health Investors, Inc. Stocks
This article lists various Exchange Traded Funds (ETFs) that hold stocks of National Health Investors, Inc. The ETFs are sorted by market value and include details such as weight, issuer, management style, focus, expense ratio, AUM, price change, and 3-year NAV total return. The …
(INBX) Volatility Zones as Tactical Triggers
This article analyzes Inhibrx Biosciences Inc Com (NASDAQ: INBX), highlighting positive near-term sentiment within a long-term strength context, despite a mid-term weak bias. It identifies elevated downside risk and provides AI-generated institutional trading strategies for different risk profiles. The analysis includes position trading, momentum …
SABESP Partners with Vivo and IDEMIA Secure Transactions, to Power the World's Largest IoT Initiative for a Secure and More Sustainable Water Management in Brazil
SABESP, the water and sanitation company of the State of São Paulo, Brazil, announces the deployment of the world's largest Internet of Things (IoT) connectivity project for smart water management. The initiative is being implemented in partnership with Telefonica/Vivo, a key player in Brazil's …